mRNA-encoded trispecific CD19×BCMA×CD3 TCE
/ METiS TechBio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
A mRNA-encoded trispecific CD19xBCMAxCD3 T cell engager to treat cancer and autoimmunity
(AACR 2026)
- "This mRNA-encoded trispecific CD19×BCMA×CD3 TCE demonstrates potent and broad B-cell and plasma-cell depletion, anti-tumor activity, and an improved safety profile, supporting ongoing First-in-Human clinical evaluation."
First-in-human • Trispecific • Hematological Malignancies • Multiple Myeloma • Oncology • CD34
1 to 1
Of
1
Go to page
1